Disentangling the Value of Technological Platforms in Life Sciences: The Case of Enabling Technologies for R&D at Bayer
Type
conference paper
Date Issued
2015-06-26
Author(s)
Abstract
In this article, we analyzed the value creation patterns of technological platforms, applied in a life science context. For that matter, we conducated a multi case study at Bayer, a worldwide leading life science company. On this ground, we were able to describe two core value patterns. Thus, platforms create value by improving the R&D processes in terms of efficiency and effectivity leading towards time and cost savings. On the other hand, they can be the basis of the discovery of new compounds resulting in new products. By increasing the scope of the platform application, these values get multiplied boosting the overall value of the platform. Furthermore, we discovered additional value multiplication effects for external R&D platforms, which access an innovation ecosystem of various researchers and platform users.
Language
English
HSG Classification
contribution to scientific community
HSG Profile Area
SoM - Business Innovation
Refereed
Yes
Start page
10
Event Title
R&D Management Conference (RADMA) 2015
Event Location
Pisa
Event Date
23.-26.06.2015
Subject(s)
Division(s)
Eprints ID
242602
File(s)![Thumbnail Image]()
open.access
Name
LingensMoser_RADMA2015.pdf
Size
330.91 KB
Format
Adobe PDF
Checksum (MD5)
e3fcc33944010d9ae225d7f657732d43